WHO news

1. Public health, influenza experts agree H5N1 research critical, but extend delay
   17 February 2012 -- Public health and influenza experts reached consensus on two urgent issues related to the newly created H5N1 influenza viruses: extending the temporary moratorium on research with new laboratory-modified H5N1 viruses and recognizing that research on naturally-occurring H5N1 influenza virus must continue in order to protect public health.
2. WHO upholds guidance on hormonal contraceptive use and HIV
   16 February 2012 -- WHO has concluded that women living with HIV or at high risk of HIV can safely continue to use hormonal contraceptives to prevent pregnancy. The recommendation follows a thorough review of evidence about links between hormonal contraceptive use and HIV acquisition.
3. WHO to issue guidance on hormonal contraceptives and HIV
   3 February 2012 -- Current WHO guidelines call on health service providers to remind patients, that neither hormonal contraceptives nor intrauterine devices known as IUDs offer protection against HIV or other sexually transmitted infections. Protection against both unwanted pregnancy and STIs including HIV is called "dual protection" and condoms are the mainstay of dual protection.
4. Dr Margaret Chan nominated for a second term to be WHO Director-General
   18 January 2012 -- Dr Margaret Chan was nominated today by the WHOs Executive Board for a second term as Director-General of the Organization. If confirmed by the World Health Assembly, Dr Chan's new term will begin on 1 July 2012 and continue until 30 June 2017.
5. Executive Board appoints the Regional Director for the WHO Eastern Mediterranean Region
   17 January 2012 -- Dr Ala Alwan will take up his appointment as the Regional Director of WHO's Eastern Mediterranean Region (WHO/EMRO) for a five-year term starting on 1 February 2012.